The Working Party on the protection of individuals with regard to the processing of personal data is an independent European advisory group on data protection and privacy that was set up under Article 29 of Directive 95/46/EC. On 10 April 2018, the Working Party...
Evaluation of EMA fee system for the approval and monitoring of medicines: public consultation has been launched
The European Commission has launched a public consultation as a part of a study supporting the evaluation of the fee system for the European Medicines Agency’s (EMA) activities relating to the approval and monitoring of medicines for people and animals. The study,...
SAVE THE DATE: iCAN’s fourth annual Research & Advocacy in Edinburgh, July 9-13, 2018
iCAN (international Children Advisory Network) fourth annual Research & Advocacy Summit will take place on July 9-13, 2018 in Edinburgh and for the first time the members of KIDS Bari, the first Italian YPAG (Young Patient Advisory Group), and KIDS Albania will...
TEDDY will participate to the tenth annual workshop of the European Network of Paediatric Research at EMA (Enpr-EMA), 7–8 June 2018
On 7th-8th June 2018, the European Network of Paediatric Research at EMA (Enpr-EMA) will hold its tenth annual workshop, bringing relevant stakeholders together to discuss requirements, barriers and opportunities for the conduct of high-quality clinical studies in...
22nd May 2018, 3rd National Clinical Trials Day
On 22nd May 2018, the Third National Clinical Trial Day was held in Prague under the auspices of the Vice-chairman of the Committee on Health and Social Policy of the Senate of the Parliament of the Czech Republic, with the cooperation of Czech Clinical Research...
TEDDY Network as EMA stakeholder at the Second International Awareness Session for International regulators, academia and non-governamental organisations
On 8-9 March 2018, the European Medicines Agency (EMA) held “the Second International Awareness Session for international regulators, academia and non-governmental organisations”. The meeting provided the occasion to present an overall overview on how the European...
Save the date – “EPTRI: a new European Research Infrastructure to foster the translation research in paediatrics”, April 10th, Bari (Italy)
The next meeting of the ID-EPTRI (European Paediatric Translational Research Infrastructure) project, entitled “EPTRI: una nuova Infrastruttura Europea per favorire la Ricerca Traslazionale in Pediatria” (EPTRI: a new European Research Infrastructure to foster the...
A new chance for the treatment of neonatal diabetes mellitus: CHMP recommends granting the marketing authorization for Amglidia
In February 2018, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization in the European Union for Amglidia, a medicine indicated for the treatment of neonatal diabetes mellitus...
TEDDY supports the Rare Disease Day 2018
TEDDY Network is pleased to support the Rare Disease Day 2018, that took place on February 28th, to raise awareness of rare diseases and their impact on patients' lives amongst the general public and decision-makers. The Rare Disease Day was first launched...
EMA Videos on why EMA matters to European citizens
The European Medicines Agency (EMA) has published on EMA’s website and on the official EMA YouTube channel, three video animations to explain how it ensures that medicines are effective and safe for the benefit of patients across the European Economic Area (EEA). The...